Botanix Pharmaceuticals Ltd (BOT:ASX)

16.5¢

right-arrow Created with Sketch. 0.02 (13.79%)
MCAP
Last trade 16.10pm 21/01/2021 20mins delayed

Latest Announcements

20/01/2021 Price SensitivePSBOTBotanix Pharmaceuticals Ltd
17/12/2020BOTBotanix Pharmaceuticals Ltd
14/12/2020 Price SensitivePSBOTBotanix Pharmaceuticals Ltd
23/11/2020BOTBotanix Pharmaceuticals Ltd
33,083
MCap
23/11/2020BOTBotanix Pharmaceuticals Ltd
4,506
MCap
11/11/2020 Price SensitivePSBOTBotanix Pharmaceuticals Ltd
21/10/2020BOTBotanix Pharmaceuticals Ltd
21/10/2020BOTBotanix Pharmaceuticals Ltd

Company Overview

Botanix Pharmaceuticals Limited, formerly Bone Medical Limited, is a pharmaceutical company. The Company focuses on developing medical dermatology products for dermatologists and their patients. Its segments include Research & Development and Corporate. The Company's products and pipeline products are all based on drug delivery technology known as Permetrex, which helps solve the challenge of delivering active pharmaceutical ingredients across the skin. The Company's products, which are under development, are focused on modulating the body's endocannabinoid system of receptors which regulates skin function, growth and renewal. Its product pipeline includes BTX1503, BTX1308 and BTX1204. Its BTX1503 is a transdermal gel formulation used for the treatment of serious acne in adults and teenagers. Its BTX1308 is a transdermal gel formulation used for the treatment of plaque psoriasis. Its BTX1204 is a transdermal gel formation used for the treatment of atopic dermititis.

BOT in the news

Search Previous Announcements